Mupirocin and Taltz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mupirocin (mupirocin) and Taltz (ixekizumab). Common drug interactions include streptococcal infection among females and psoriasis among males.

The phase IV clinical study analyzes what interactions people have when they take Mupirocin and Taltz. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Mupirocin?

Mupirocin has active ingredients of mupirocin. It is often used in impetigo. eHealthMe is studying from 5,940 Mupirocin users. Check the latest studies of Mupirocin.

What is Taltz?

Taltz has active ingredients of ixekizumab. eHealthMe is studying from 29,777 Taltz users. Check the latest studies of Taltz.



On Jul, 26, 2026

11 people who take Mupirocin and Taltz together, and have interactions are studied.

Mupirocin and Taltz drug interactions.

What are the common drug interactions of Mupirocin and Taltz, by gender? *:

female:

  1. Streptococcal infection
  2. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  3. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  4. Pneumococcal sepsis (pneumococcal sepsis is a serious medical condition where bacteria, specifically streptococcus pneumoniae)
  5. Purpura fulminans (destructive infections that involve both skin and soft tissues)
  6. Septic shock (shock due to blood infection)
  7. Chest pain
  8. Conjunctivitis (pink eye)
  9. Drug ineffective
  10. Dyspnoea (difficult or laboured respiration)

male:

  1. Psoriasis (immune-mediated disease that affects the skin)
  2. Arthralgia (joint pain)
  3. Helminthic infection (worms infection)
  4. Infection parasitic
  5. Irritable bowel syndrome
  6. Peripheral swelling
  7. Productive cough
  8. Pruritus (severe itching of the skin)
  9. Sinusitis (inflammation of sinus)
  10. Skin disorder (skin disease)

What are the common drug interactions of Mupirocin and Taltz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  2. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  3. Pneumococcal sepsis (pneumococcal sepsis is a serious medical condition where bacteria, specifically streptococcus pneumoniae)
  4. Purpura fulminans (destructive infections that involve both skin and soft tissues)
  5. Septic shock (shock due to blood infection)

30-39:

  1. Fungal infection
  2. Pharyngitis (inflammation of the pharynx, causing a sore throat)

40-49:

  1. Helminthic infection (worms infection)
  2. Infection parasitic
  3. Irritable bowel syndrome
  4. Productive cough
  5. Pruritus (severe itching of the skin)
  6. Psoriasis (immune-mediated disease that affects the skin)
  7. Sinusitis (inflammation of sinus)
  8. Skin disorder (skin disease)
  9. Staphylococcal skin infection (skin infection by an infection with staphylococcus bacteria)
  10. Varicose vein (veins that have become enlarged and tortuous)

50-59:

  1. Conjunctivitis (pink eye)
  2. Drug ineffective
  3. Rash
  4. Scratch
  5. Skin haemorrhage (bleeding into skin)
  6. Wound

60+:

n/a

What are the existing conditions these people have? *

  1. Psoriasis (immune-mediated disease that affects the skin): 8 people, 72.73%
  2. Pain: 2 people, 18.18%
  3. Wound: 1 person, 9.09%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
  5. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 9.09%
  6. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 9.09%
  7. Drowsiness: 1 person, 9.09%
  8. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 9.09%
  9. Fungal Infection: 1 person, 9.09%
  10. Joint Pain: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Mupirocin and Taltz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mupirocin and Taltz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mupirocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Taltz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mupirocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Taltz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mupirocin and ixekizumab (the active ingredients of Mupirocin and Taltz, respectively), and Mupirocin and Taltz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: